Methylation-Specific PCR Unraveled

Methylation‐specific PCR (MSP) is a simple, quick and cost‐effective method to analyze the DNA methylation status of virtually any group of CpG sites within a CpG island. The technique comprises two parts: (1) sodium bisulfite conversion of unmethylated cytosine's to uracil under conditions whereby methylated cytosines remains unchanged and (2) detection of the bisulfite induced sequence differences by PCR using specific primer sets for both unmethylated and methylated DNA. This review discusses the critical parameters of MSP and presents an overview of the available MSP variants and the (clinical) applications.

[1]  F. Gilliland,et al.  Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. , 2002, Cancer research.

[2]  Jing Yi,et al.  Detection of aberrant p16 methylation in the serum of colorectal cancer patients. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  A. Schinzel,et al.  A novel MSP/DHPLC method for the investigation of the methylation status of imprinted genes enables the molecular detection of low cell mosaicisms , 2001, Human mutation.

[4]  J. Herman,et al.  Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. , 1999, Cancer research.

[5]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Yoram Cohen,et al.  Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study. , 2004, Molecular cancer research : MCR.

[7]  Christopher B Umbricht,et al.  Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR , 2001, The Lancet.

[8]  R Alexandra Goldbohm,et al.  Effects of dietary folate and alcohol intake on promoter methylation in sporadic colorectal cancer: the Netherlands cohort study on diet and cancer. , 2003, Cancer research.

[9]  Diane D. Liu,et al.  Aberrant promoter methylation of multiple genes in bronchial brush samples from former cigarette smokers. , 2002, Cancer research.

[10]  G. Coetzee,et al.  5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. , 1990, Science.

[11]  S. Clark,et al.  Cytosines adjacent to methylated CpG sites can be partially resistant to conversion in genomic bisulfite sequencing leading to methylation artifacts. , 1998, Analytical biochemistry.

[12]  T. Kinoshita,et al.  Clonality analysis by methylation-specific PCR for the human androgen-receptor gene (HUMARA-MSP) , 2000, Leukemia.

[13]  Y. Roussos,et al.  O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  D. Sidransky,et al.  Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. , 2002, Cancer research.

[15]  M. Hoque,et al.  Quantitative RARbeta2 hypermethylation: a promising prostate cancer marker. , 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  K. Miller,et al.  DNA‐Based Detection of Prostate Cancer in Blood, Urine, and Ejaculates , 2001, Annals of the New York Academy of Sciences.

[18]  J. Herman,et al.  Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. , 2003, The American journal of pathology.

[19]  D. Natale,et al.  Absence of an Unusual “Densely Methylated Island” at the Hamster dhfr ori-β* , 1997, The Journal of Biological Chemistry.

[20]  D. Hornby,et al.  An analytical method for the detection of methylation differences at specific chromosomal loci using primer extension and ion pair reverse phase HPLC , 2002, Human mutation.

[21]  D. Ledbetter,et al.  Methylation-specif ic PCR simplifies imprinting analysis , 1997, Nature genetics.

[22]  K D Robertson,et al.  DNA methylation: past, present and future directions. , 2000, Carcinogenesis.

[23]  Pedram Argani,et al.  Quantitative Multiplex Methylation-Specific PCR Assay for the Detection of Promoter Hypermethylation in Multiple Genes in Breast Cancer , 2004, Cancer Research.

[24]  D. Sidransky,et al.  Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. , 2001, Journal of the National Cancer Institute.

[25]  P. Laird,et al.  MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.

[26]  Y. Lo,et al.  Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction. , 1999, Cancer research.

[27]  Long-Cheng Li,et al.  MethPrimer: designing primers for methylation PCRs , 2002, Bioinform..

[28]  M. Widschwendter,et al.  DNA Methylation in Serum and Tumors of Cervical Cancer Patients , 2004, Clinical Cancer Research.

[29]  W. Schulz,et al.  Denaturing high‐performance liquid chromatography (DHPLC) as a reliable high‐throughput prescreening method for aberrant promoter methylation in cancer , 2004, Human mutation.

[30]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[31]  A. Olek,et al.  A real-time PCR assay for DNA-methylation using methylation-specific blockers. , 2004, Nucleic acids research.

[32]  W. Lau,et al.  Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  Manel Esteller,et al.  DNA methylation: a profile of methods and applications. , 2002, BioTechniques.

[34]  Rui Henrique,et al.  Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer. , 2002, Urology.

[35]  Hiroshi Nakayama,et al.  Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. , 2002, Cancer letters.

[36]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[37]  L. Lerman,et al.  Comprehensive detection of single base changes in human genomic DNA using denaturing gradient gel electrophoresis and a GC clamp. , 1990, Genomics.

[38]  S. Groshen,et al.  Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer: associations with clinical outcome. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[39]  J. Jen,et al.  Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. , 2001, Cancer research.

[40]  J. Herman,et al.  Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. , 2000, Cancer research.

[41]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[42]  S. Groshen,et al.  Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. , 2000, Journal of the National Cancer Institute.

[43]  J. Herman,et al.  In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[44]  A. Bird,et al.  Methylation-Induced Repression— Belts, Braces, and Chromatin , 1999, Cell.

[45]  H. Kuwano,et al.  High frequency of DAP-kinase gene promoter methylation in colorectal cancer specimens and its identification in serum. , 2003, Cancer letters.

[46]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[47]  A. Wolffe,et al.  How does DNA methylation repress transcription? , 1997, Trends in genetics : TIG.

[48]  J. Herman,et al.  Predicting lung cancer by detecting aberrant promoter methylation in sputum. , 2000, Cancer research.

[49]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[50]  J. Epstein,et al.  Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma. , 2003, The Journal of urology.

[51]  E. İskender,et al.  Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract , 2004, International journal of cancer.

[52]  P. Laird.  Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.

[53]  J. Lutterbaugh,et al.  Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. , 2001, Cancer research.

[54]  M. Frommer,et al.  CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.

[55]  A. Baumer.  Analysis of the methylation status of imprinted genes based on methylation-specific polymerase chain reaction combined with denaturing high-performance liquid chromatography. , 2002, Methods.

[56]  A. Nakao,et al.  Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients , 2003, International journal of cancer.

[57]  W. Lau,et al.  Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[58]  U. Lehmann,et al.  Quantitative assessment of promoter hypermethylation during breast cancer development. , 2002, The American journal of pathology.

[59]  W. Thilly,et al.  Resolution of a missense mutant in human genomic DNA by denaturing gradient gel electrophoresis and direct sequencing using in vitro DNA amplification: HPRT Munich. , 1988, American journal of human genetics.

[60]  J. Herman,et al.  Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours , 2002, The Journal of pathology.

[61]  Peter Molloy,et al.  Conversion-specific detection of DNA methylation using real-time polymerase chain reaction (ConLight-MSP) to avoid false positives. , 2002, Methods.

[62]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.